Literature DB >> 22413977

Changing epidemiology and mortality in adult congenital heart disease: looking into the future.

Matthias Greutmann1, Daniel Tobler.   

Abstract

Advances in surgical and medical treatment of children born with congenital heart disease have led to a growing number of adult survivors, particularly to a growing number of adults with complex congenital heart disease. Childhood mortality has continuously decreased over the last few decades and mortality has shifted almost entirely to adulthood. However, most patients are not cured and many remain at risk of premature death. The extent of excess mortality among individual congenital disease entities is not well defined. In this article we outline the current demographics of adults with selected congenital heart lesions. Based on these contemporary patient cohorts, we delineate future changes in patient demographics. A better understanding of these trends may help in the optimal planning of future resource allocation for medical care and optimal planning of multicenter research, for this novel and growing population of young, chronically ill adults.

Entities:  

Mesh:

Year:  2012        PMID: 22413977     DOI: 10.2217/fca.12.6

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  14 in total

1.  Adolescents and adults with congenital heart diseases in oman.

Authors:  Asim Al-Balushi; Hamood Al-Kindi; Hamood Al-Shuaili; Suresh Kumar; Salim Al-Maskari
Journal:  Oman Med J       Date:  2015-01

Review 2.  Elevated serum levels of ghrelin and TNF-α in patients with cyanotic and acyanotic congenital heart disease.

Authors:  Sai Zhang; Gong-Liang Guo; Li-Li Yang; Li-Qun Sun
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

3.  A novel NKX2.6 mutation associated with congenital ventricular septal defect.

Authors:  Juan Wang; Jian-Hui Mao; Ke-Ke Ding; Wei-Jun Xu; Xing-Yuan Liu; Xing-Biao Qiu; Ruo-Gu Li; Xin-Kai Qu; Ying-Jia Xu; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

4.  Association of TGFBR2 rs6785358 Polymorphism with Increased Risk of Congenital Ventricular Septal Defect in a Chinese Population.

Authors:  Xiang-Ting Li; Chang-Qing Shen; Rui Zhang; Ji-Kui Shi; Zong-Hong Li; Hong-Yu Liu; Bo Sun; Kai Wang; Li-Ru Yan
Journal:  Pediatr Cardiol       Date:  2015-05-30       Impact factor: 1.655

5.  [Adult patients with congenital heart disease].

Authors:  R G Grabitz; H Kaemmerer; F-W Mohr
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

Review 6.  Heart failure in congenital heart disease: a confluence of acquired and congenital.

Authors:  Akl C Fahed; Amy E Roberts; Seema Mital; Neal K Lakdawala
Journal:  Heart Fail Clin       Date:  2014-01       Impact factor: 3.179

7.  Association between 5, 10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and congenital heart disease: A meta-analysis.

Authors:  Wenju Wang; Zongliu Hou; Chunhui Wang; Chuanyu Wei; Yaxiong Li; Lihong Jiang
Journal:  Meta Gene       Date:  2013-10-28

8.  Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years.

Authors:  Laura Llamosas-Falcón; Eva Bermejo-Sánchez; Germán Sánchez-Díaz; Ana Villaverde-Hueso; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Orphanet J Rare Dis       Date:  2019-04-08       Impact factor: 4.123

9.  Percutaneous closure of traumatic ventricular septal defects: device selection and reasoning.

Authors:  Jian Zhu; Er-Ping Xi; Shui-Bo Zhu
Journal:  Clinics (Sao Paulo)       Date:  2014-02       Impact factor: 2.365

10.  Human fetal heart specific coexpression network involves congenital heart disease/defect candidate genes.

Authors:  Bo Wang; Guoling You; Qihua Fu
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.